Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Norfloxacin | 1 | 2019 | 13 | 0.79 | Why? |
| Viral Hepatitis Vaccines | 1 | 2019 | 58 | 0.76 | Why? |
| Natural Killer T-Cells | 1 | 2020 | 191 | 0.75 | Why? |
| Schistosoma mansoni | 1 | 2017 | 27 | 0.70 | Why? |
| Schistosomiasis mansoni | 1 | 2017 | 35 | 0.69 | Why? |
| Lymphoma, T-Cell | 1 | 2017 | 70 | 0.68 | Why? |
| Candida glabrata | 1 | 2017 | 50 | 0.67 | Why? |
| Quinolones | 1 | 2019 | 167 | 0.67 | Why? |
| Hepatitis A | 1 | 2019 | 140 | 0.66 | Why? |
| Dermatomycoses | 1 | 2017 | 55 | 0.65 | Why? |
| Hypertension, Portal | 1 | 2017 | 73 | 0.64 | Why? |
| Hepacivirus | 4 | 2019 | 1509 | 0.64 | Why? |
| Peritonitis | 1 | 2019 | 217 | 0.64 | Why? |
| Equilibrative Nucleoside Transporter 1 | 1 | 2015 | 5 | 0.63 | Why? |
| Pyrophosphatases | 1 | 2015 | 39 | 0.60 | Why? |
| Hepatitis C | 2 | 2019 | 1514 | 0.59 | Why? |
| Killer Cells, Natural | 3 | 2020 | 2093 | 0.59 | Why? |
| Liver Cirrhosis | 3 | 2019 | 1810 | 0.50 | Why? |
| Candidiasis | 1 | 2017 | 334 | 0.49 | Why? |
| Disease Eradication | 1 | 2019 | 581 | 0.47 | Why? |
| Leukocytes, Mononuclear | 2 | 2021 | 2115 | 0.46 | Why? |
| Immunization | 1 | 2021 | 2019 | 0.45 | Why? |
| Hepatitis B, Chronic | 1 | 2017 | 616 | 0.42 | Why? |
| Hepatitis B virus | 1 | 2017 | 882 | 0.40 | Why? |
| Homosexuality, Male | 1 | 2019 | 1158 | 0.40 | Why? |
| Lymphocytes | 1 | 2021 | 3056 | 0.36 | Why? |
| Ribavirin | 1 | 2015 | 1182 | 0.35 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.35 | Why? |
| Personnel, Hospital | 1 | 2021 | 2273 | 0.33 | Why? |
| Delivery of Health Care, Integrated | 1 | 2019 | 1549 | 0.33 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.30 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.29 | Why? |
| Bacterial Infections | 1 | 2019 | 2229 | 0.29 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.29 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.28 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.26 | Why? |
| Fever | 1 | 2020 | 7795 | 0.25 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.23 | Why? |
| Uveitis, Anterior | 1 | 2021 | 71 | 0.21 | Why? |
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2019 | 14 | 0.20 | Why? |
| Hospitals, University | 3 | 2021 | 4173 | 0.20 | Why? |
| Macrocyclic Compounds | 1 | 2019 | 78 | 0.19 | Why? |
| Receptors, Interleukin-1 | 1 | 2020 | 161 | 0.19 | Why? |
| Protease Inhibitors | 1 | 2015 | 3630 | 0.19 | Why? |
| Methicillin Resistance | 1 | 2018 | 77 | 0.19 | Why? |
| Carcinoma, Hepatocellular | 2 | 2019 | 1222 | 0.19 | Why? |
| Portal Pressure | 1 | 2017 | 13 | 0.18 | Why? |
| Heterocyclic Compounds, 4 or More Rings | 1 | 2019 | 139 | 0.18 | Why? |
| Uveitis | 1 | 2021 | 233 | 0.18 | Why? |
| Lymphoproliferative Disorders | 1 | 2019 | 110 | 0.17 | Why? |
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2017 | 47 | 0.17 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.17 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.17 | Why? |
| CD56 Antigen | 1 | 2017 | 193 | 0.17 | Why? |
| Liver Neoplasms | 2 | 2019 | 1666 | 0.16 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.16 | Why? |
| Diffusion of Innovation | 1 | 2021 | 440 | 0.16 | Why? |
| Immunophenotyping | 1 | 2021 | 1290 | 0.16 | Why? |
| Carbamates | 1 | 2019 | 485 | 0.15 | Why? |
| CD4 Lymphocyte Count | 1 | 2020 | 1517 | 0.15 | Why? |
| Antiviral Agents | 4 | 2021 | 41703 | 0.14 | Why? |
| Global Health | 1 | 2019 | 13911 | 0.14 | Why? |
| Health Services Accessibility | 1 | 2019 | 10697 | 0.14 | Why? |
| Sofosbuvir | 1 | 2019 | 518 | 0.14 | Why? |
| Italy | 6 | 2021 | 38444 | 0.14 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.14 | Why? |
| Proline | 1 | 2015 | 345 | 0.13 | Why? |
| HIV Infections | 1 | 2019 | 11620 | 0.12 | Why? |
| Dysbiosis | 1 | 2019 | 685 | 0.12 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 1165 | 0.12 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.12 | Why? |
| Humans | 25 | 2021 | 930598 | 0.11 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.11 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.11 | Why? |
| Host-Pathogen Interactions | 2 | 2021 | 11041 | 0.11 | Why? |
| Disease Outbreaks | 1 | 2019 | 27595 | 0.10 | Why? |
| Sulfonamides | 1 | 2019 | 1294 | 0.10 | Why? |
| Hepatitis C, Chronic | 1 | 2019 | 973 | 0.10 | Why? |
| Methylprednisolone | 1 | 2020 | 2107 | 0.10 | Why? |
| Hemoglobins | 1 | 2015 | 958 | 0.10 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.09 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.09 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.09 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
| Anemia | 1 | 2015 | 789 | 0.09 | Why? |
| Female | 13 | 2021 | 380317 | 0.09 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.08 | Why? |
| Male | 12 | 2021 | 367725 | 0.08 | Why? |
| Adult | 8 | 2021 | 244371 | 0.08 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.08 | Why? |
| Drug Therapy, Combination | 2 | 2020 | 7268 | 0.08 | Why? |
| Electronic Health Records | 1 | 2019 | 3492 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
| Monocytes | 1 | 2017 | 2978 | 0.07 | Why? |
| Genotype | 1 | 2015 | 4697 | 0.06 | Why? |
| Clonal Evolution | 1 | 2021 | 55 | 0.06 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2015 | 3607 | 0.06 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.06 | Why? |
| Pregnancy | 2 | 2021 | 23879 | 0.06 | Why? |
| Cell Plasticity | 1 | 2021 | 75 | 0.06 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.06 | Why? |
| Animals | 3 | 2021 | 78931 | 0.05 | Why? |
| Risk Factors | 3 | 2019 | 71621 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2019 | 8248 | 0.05 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.05 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.05 | Why? |
| Aged | 6 | 2021 | 215776 | 0.05 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.05 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.05 | Why? |
| Immunoglobulin Isotypes | 1 | 2021 | 308 | 0.05 | Why? |
| Retreatment | 1 | 2019 | 186 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Tumor Cells, Cultured | 1 | 2019 | 254 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.05 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Protein Isoforms | 1 | 2019 | 347 | 0.04 | Why? |
| Receptors, Interleukin | 1 | 2017 | 83 | 0.04 | Why? |
| Sustained Virologic Response | 1 | 2019 | 378 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
| Prevalence | 1 | 2019 | 25773 | 0.04 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 245 | 0.04 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.04 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2019 | 1083 | 0.03 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.03 | Why? |
| Gene Expression Profiling | 1 | 2021 | 3788 | 0.02 | Why? |
| Child | 1 | 2019 | 70012 | 0.02 | Why? |
| Drug Combinations | 1 | 2019 | 3852 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.02 | Why? |
| Precision Medicine | 1 | 2019 | 1477 | 0.02 | Why? |
| Microbiota | 1 | 2019 | 1240 | 0.02 | Why? |
| Adolescent | 1 | 2019 | 86841 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.02 | Why? |
| Gastrointestinal Microbiome | 1 | 2019 | 1961 | 0.02 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.02 | Why? |
| Viral Nonstructural Proteins | 1 | 2019 | 4810 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Virus Replication | 1 | 2017 | 14331 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
Lombardi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(160)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(145)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_